4-Hydroxy-5-hydroxymethyl-2-oxo-2,5-dihydro-furan-3-carboxylic acid 16-allyloxycarbonylamino-hexadecyl ester

ID: ALA110983

Chembl Id: CHEMBL110983

Max Phase: Preclinical

Molecular Formula: C26H43NO8

Molecular Weight: 497.63

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CCOC(=O)NCCCCCCCCCCCCCCCCOC(=O)C1=C(O)O[C@H](CO)C1=O

Standard InChI:  InChI=1S/C26H43NO8/c1-2-18-34-26(32)27-17-15-13-11-9-7-5-3-4-6-8-10-12-14-16-19-33-24(30)22-23(29)21(20-28)35-25(22)31/h2,21,28,31H,1,3-20H2,(H,27,32)/t21-/m1/s1

Standard InChI Key:  YEIGRGPPDOBAOL-OAQYLSRUSA-N

Alternative Forms

  1. Parent:

    ALA110983

    ---

Associated Targets(Human)

DUSP3 Tchem Dual specificity protein phosphatase 3 (1161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cdc25b Dual specificity phosphatase Cdc25B (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 497.63Molecular Weight (Monoisotopic): 497.2989AlogP: 4.63#Rotatable Bonds: 21
Polar Surface Area: 131.39Molecular Species: ACIDHBA: 8HBD: 3
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 0.36CX Basic pKa: CX LogP: 6.14CX LogD: 2.57
Aromatic Rings: 0Heavy Atoms: 35QED Weighted: 0.09Np Likeness Score: 0.34

References

1. Sodeoka M, Sampe R, Kojima S, Baba Y, Usui T, Ueda K, Osada H..  (2001)  Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.,  44  (20): [PMID:11563920] [10.1021/jm0100741]

Source